Press releases
- Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
- Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
- Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
More ▼
Key statistics
On Wednesday, Enanta Pharmaceuticals Inc (9EP:DEU) closed at 13.40, -25.97% below its 52-week high of 18.10, set on Aug 07, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.70 |
---|---|
High | 13.70 |
Low | 13.40 |
Bid | 13.80 |
Offer | 13.90 |
Previous close | 13.40 |
Average volume | 10.00 |
---|---|
Shares outstanding | 21.18m |
Free float | 19.89m |
P/E (TTM) | -- |
Market cap | 317.48m USD |
EPS (TTM) | -6.25 USD |
Data delayed at least 15 minutes, as of Jul 24 2024.
More ▼